2019 February 6 - IDSA News

Read the last issue of IDSA News

IDSA/HIVMA Leaders Respond to State of the Union Address

Reports that President Trump in his State of the Union address would announce plans to end America’s HIV epidemic by 2030 raised hopes and questions among infectious disease and HIV experts.

Apply to Serve on IDSA Board of Directors

IDSA is seeking volunteers to apply to serve on the Board of Directors.

Draft Legislation Would Delay and Eliminate Laboratory Developed Testing for Infectious Diseases

Congress is considering draft legislation that would initiate FDA regulation of laboratory developed tests (LDTs). The bill would also set back transplant medicine by 20 years and severely limit the availability of diagnostics for rare infectious diseases, emerging diseases, and unmet needs.

Journal Club

In this feature, a panel of IDSA members identifies and critiques important new studies in the current literature that have a significant impact on the practice of infectious diseases medicine.
Reviews in this issue: Just What the C-Suite Ordered: An FTE-to-Bed Ratio to Guide ASP Discussions; Addiction Medicine Consultation for Patients with Opioid Use Disorder Admitted for Infections; Should Routine HIV PrEP Follow-Up Include HCV Screening?

Opportunity for Public Comment: The Appropriate Treatment of Initial C diff Infection Clinical Quality Measure Concept

IDSA’s Quality Improvement Committee (QIC) is seeking feedback on the Appropriate Treatment of Initial Clostridium difficile Infection (CDI) clinical quality measure concept.

IDSA Measles Resources Available Online

The declaration of a public health emergency in the state of Washington in January 2019, after confirmation of 26 measles cases there, follows a report in December 2018 showing steep climbs and severe outbreaks of the virus worldwide.

IDSA Urges Congress to Increase its Global Fund Commitment

The United States will join with other donor countries in October to pledge commitments to the Global Fund to Fight AIDS, TB and Malaria for the next three years.

ID Research Careers Meeting Registration

Registration will open on Thursday, Feb. 7 for the 8^th Annual Infectious Diseases (ID) Research Careers Meeting, cosponsored by IDSA and the National Institute of Allergy and Infectious Diseases (NIAID).

Updated ID & Opioids Resources

HIVMA and IDSA recently updated the Infectious Diseases and the Opioid Epidemic online resource page.

IDSA Supporting Medical Student Education on AMR and Stewardship

At the invitation of IDSA members, Amanda Jezek, IDSA’s Senior Vice President of Public Policy and Government Affairs, spoke recently to a group of medical students at Albert Einstein College of Medicine about federal policy efforts to address antimicrobial resistance and promote antimicrobial stewardship and opportunities for medical students to conduct research on AMR and engage in advocacy on this issue.

Science Speaks

IDSA’s Science Speaks blog discusses the new chair and five new members of the powerful House Energy and Commerce Health Subcommittee.

IDSA & ID in the News

Healio spoke with IDSA spokesperson Kathryn Edwards, MD, FIDSA to get her perspective on findings from a recent study published in Annals of Family Medicine which reports that “repeated inactivated influenza immunization appeared to increase long-term protection against some respiratory illness episodes in children with pre-existing medical conditions.”

ICYMI: What’s Hot on MyIDSA

Here’s a glance at the latest discussions happening on MyIDSA, IDSA’s members-only online community (login required).